# Evaluating the Safety and Efficacy of Drug-Coated Autoperfusion Balloons Versus Conventional Drug-Coated Balloons Guided by IVUS-OCT Multimodal Imaging for Treating Acute Myocardial Infarction: OPERA-AMI Study

Study · id `cardio:ct-nct06794801` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06794801](<https://clinicaltrials.gov/study/NCT06794801>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06794801

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 134 participants.

## Technical summary

Registry record NCT06794801. Randomized; no masking; primary purpose treatment. Start 2025-01 (anticipated); primary completion 2026-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 134 participants (planned count; ClinicalTrials.gov record NCT06794801, source copy `cardio:ctgov-nct06794801-2025-01-27`, retrieved 2026-10-26)
- Planned start: 2025-01 (anticipated) (ClinicalTrials.gov record NCT06794801, source copy `cardio:ctgov-nct06794801-2025-01-27`, retrieved 2026-10-26)
- Primary completion: 2026-12 (anticipated) (ClinicalTrials.gov record NCT06794801, source copy `cardio:ctgov-nct06794801-2025-01-27`, retrieved 2026-10-26)
- Completion: 2030-12 (anticipated) (ClinicalTrials.gov record NCT06794801, source copy `cardio:ctgov-nct06794801-2025-01-27`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT06794801, source copy `cardio:ctgov-nct06794801-2025-01-27`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06794801-2025-01-27`, retrieved 2026-10-26)

## The registry's words

- Brief title: Evaluating the Safety and Efficacy of Drug-Coated Autoperfusion Balloons Versus Conventional Drug-Coated Balloons Guided by IVUS-OCT Multimodal Imaging for Treating Acute Myocardial Infarction: OPERA-AMI Study
- Condition: ST Segment Elevation Myocardial Infarction (STEMI)
- Intervention (Device): Drug Coated Autoperfusion Balloon Dilatation Catheter（DCAB）
- Intervention (Device): Conventional Drug coated balloon (DCB)
- Lead sponsor: LanZhou University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry lists this organization as the lead sponsor: LanZhou University (`cardio:org-lanzhou-university`)

## Provenance

Content hash: 1cfb2c70738923112107571e1f7b9985eacb7f6927c649e47d3385019d940fdf
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
